Mogens Groenvold
@mogensgroenvold.bsky.social
18 followers 62 following 9 posts
Posts Media Videos Starter Packs
mogensgroenvold.bsky.social
A very inspiring session indeed
mogensgroenvold.bsky.social
It was such an honour for us to host this meeting in Copenhagen and to enjoy the company os more than 200 friends and colleagues
qol.eortc.org
👏Another great meeting of @eortc.org #QualityofLife Group coming to an end.
Many projects, collaborations, inspiring discussions &exchanges of ideas💡

Thank you for joining us, see you in Berlin in April 2026!
#QLGmeeting #GivingVoice2Patients
@mogensgroenvold.bsky.social @dirkhofmeister.bsky.social
mogensgroenvold.bsky.social
Excited to host - for the third time - this meeting of a scientific group that I joined in 1989, and which has since made a very substantial contribution to its field.
qol.eortc.org
👏🏼 Welcome to the @eortc.org #QualityofLife Group autumn meeting 2025 in sunny Copenhagen! 🇩🇰

We have a packed room for the welcome session and a busy programme for the two days ahead - looking forward to another productive meeting! 💪🏼

#GivingVoice2Patients #QLGmeeting
Reposted by Mogens Groenvold
qol.eortc.org
📅 Reminder: Registration is open for the @eortc.org #QualityofLife Group (QLG) autumn meeting, to be held on 25-26 September in Copenhagen!

⏰ Register by 19th August to secure your place!

🔗More info including on venue & programme: www.eortc.org/event/eortc-...

#QLGmeeting
Reposted by Mogens Groenvold
qol.eortc.org
🚀 @eortc.org QLQ-C30 is the leading PRO measure in oncology! Since 2016, EORTC #QualityofLife Group strategy has evolved to stay ahead with cancer treatment advancements. 🌟This includes disease-specific modules, Computer Adaptive Testing (CAT), & Item Lists.

@mogensgroenvold.bsky.social #QoLConf25
Reposted by Mogens Groenvold
qol.eortc.org
🌐 The @eortc.org Item Library is an interactive platform for creating customised item lists, useful for novel treatments, early phase trials, rare disease groups & tailored clinical monitoring. 👏 Ongoing projects will expand adverse events coverage and HRQoL issues.
- C. Piccinin at #QoLConf25
Reposted by Mogens Groenvold
qol.eortc.org
🔍 The @eortc.org Computerised Adaptive Testing (CAT) is an innovative, individually responsive HRQoL measurement. CAT optimises item presentation based on prior responses, allowing for more precision and reduced response burden compared to conventional PRO questionnaires.
- H. Vachon #QoLConf25
Reposted by Mogens Groenvold
qol.eortc.org
📝The @eortc.org Write-In-Three Symptoms/Problems (WISP) instrument enables open-ended reporting of PROs, filling a crucial gap in capturing missing symptoms across various oncological settings. WISP is both acceptable and useful for patients.🌟
- C. Piccinin #QoLConf25
#CancerResearch #QualityofLife
Reposted by Mogens Groenvold
laegeforeningen.bsky.social
Skarp kritik igen: På fem år er der ikke sket nævne­værdige forbedringer af ventetiden til specialiseret lindring for patienter med livstruende sygdomme. Som samfund skal DK altså tage bedre hånd om mennesker med livstruende sygdomme #dkpol #sundpol www.rigsrevisionen.dk/revisionssag...
Beretning om ventetid til specialiseret lindring for patienter med livstruende sygdomme
Beretning nr. 17/2024
www.rigsrevisionen.dk
Reposted by Mogens Groenvold
qol.eortc.org
🔗 Often, the ‘integration of oncology & palliative care ideal’ is not a reality. The Joint Action Network of Expertise ‘JANE’ aims to bridge this gap by studying the timely integration of evidence-based palliative care into standard oncology care 🌟
@mogensgroenvold.bsky.social @eortc.org #QoLConf25
Reposted by Mogens Groenvold
qol.eortc.org
🔚 SESSION 4 focused on PROs for special cancer patient populations
Speakers: David Riedl, Anne-Sophie Darlington, Jaap Reijneveld, Paolo Bossi & Mogens Groenvold
Chairs: Dagmara Kuliś & @mogensgroenvold.bsky.social
#QoLConf25 #CancerResearch
mogensgroenvold.bsky.social
Extremely happy to see the publication of our paper describing the gradual refinement and expansion of the EORTC QLG strategy through the last decade.

Thank you to all involved for both the excellent collaboration and the courage to make significant changes.
qol.eortc.org
🌟 The @eortc.org #QualityofLife (QoL) Group's integrated strategy, outlined in new EJC publication, ensures the tools we use to assess QoL remain scientifically rigorous, clinically meaningful and responsive to patients’ voices.

🔗 www.eortc.org/blog/2025/04...
#CancerResearch #GivingVoice2Patients
eortc.org
📣 New EJC publication outlines the @qol.eortc.org forward-thinking strategy that aims to align patient-reported outcome (PRO) assessment in oncology with diverse patients' needs and evolving research & clinical settings.

🔗 Read more: www.eortc.org/blog/2025/04...

#CancerResearch #QualityofLife
Reposted by Mogens Groenvold
qol.eortc.org
🤝As the clinical trial landscape evolves, so must our strategies for measuring patients’ #QualityofLife to ensure their voice is incorporated in the decision-making process

🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu
eortc.org
🔎New in @thelancetoncol.bsky.social: Insights from @ema.europa.eu-EORTC workshop underscore the role of #QualityofLife data in cancer treatment evaluation.

It’s not just about survival-it’s also about how patients live.

Read more in our press release:
www.eortc.org/blog/2025/04...
#CancerResearch
mogensgroenvold.bsky.social
In this interview, I was invited to present my vision for how palliative care can be improved in Denmark.

The article is in Danish and was originally published in a magazine for physicians in hospitals who are not specialized in palliative care.

sundhedspolitisktidsskrift.dk/nyheder/sund...
Døende svigtes – der skal ske noget radikalt nyt med palliationen i Danmark, mener professor
Sundhedspolitisk Tidsskrift giver dig nyheder om sundhedspolitik, nye behandlinger, sundhedsøkonomi samt debat om sundhedsproblemer og -politik
sundhedspolitisktidsskrift.dk
mogensgroenvold.bsky.social
Meget fint resume - jeg har virkelig været opløftet over at have taget samme skridt og at at finde et bedre sted. Det var desuden en lettelse at slette min tidligere Twitterprofil, som jeg ellers har haft stor glæde af
svendbrinkmann.dk
Jeg har fortalt mine venner på Facebook og Instagram om min foreløbige begejstring for Bluesky.